In Silico Pharmacology Research Unit (ISPRU)
Pharos University in Alexandria (PUA)
About ISPRU:
The In Silico Pharmacology Research Unit (ISPRU) is a pioneering research hub dedicated to accelerating drug discovery through advanced computational approaches. Positioned at the intersection of pharmacology, bioinformatics, medicinal chemistry, and systems biology, ISPRU harnesses state-of-the-art in silico techniques to predict, design, and optimize new pharmaceutical compounds.
ISPRU was established to respond to the growing demand for cost-effective, high-throughput alternatives to traditional drug development pipelines. By integrating computational modeling with interdisciplinary collaboration, the unit aims to bridge the gap between theoretical innovation and clinical application. With strong regional and international collaborations, ISPRU also serves as a platform for capacity building, skills development, and translational research in the era of digital pharmacology.
Mission :
To drive impactful pharmaceutical research by applying cutting-edge computational technologies for drug discovery and development, while nurturing a new generation of researchers through world-class training, innovation, and collaboration.
Vision :
To become a regional and global leader in in silico pharmacology, advancing science through innovation, empowering researchers through training, and contributing to the discovery of safe, effective, and accessible therapeutics.